摘要
冠心病是中老年人的常见病、多发病,亦是重大疾病,严重威胁着人民的健康和生命。而目前经皮冠状动脉介入治(PCI)术后冠脉再狭窄发生率高达20%～40%。有研究证实,炎症反应是PCI术后再狭窄的关键;而TLR-4是连接炎症反应与PCI术后再狭窄的桥梁。根据辨证论治的原则,中医从多角度出发在冠心病PCI术后再狭窄的防治中发挥着重要作用。
Coronary atherosclerotic heart disease is common and frequently-occurring in the elderly, and also is a major disease ,a serious threat to the health and lives of the people. At present, the incidence rate of coronary artery restenosis is as high as 20% - 40% after percutaneous coronary intervention. Studies have confirmed that the inflammatory response is the key to coronary artery restenosis after PCI; and TLR-4 is a bridge connected the inflammatory response with restenosis after PCI. According to the principle of treatment based on syndrome differetiation,TCM plays an important role in the prevention and treatment of coronary artery restenosis after PCI from multi-angle.
出处
《辽宁中医药大学学报》
CAS
2009年第11期42-44,共3页
Journal of Liaoning University of Traditional Chinese Medicine
关键词
冠心病
PCI术后
再狭窄
中药
Coronary atherosclerotic heart disease
after PCI
restenosis
Chinese herbs
作者简介
作者简介：唐虹（1982-），女，四川成都人，2007级硕士研究生，研究方向：针药结合治疗老年病的临床与实验研究。
